Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
Department of Health and Human Services (HHS)
Pharma
FDA is moving forward with abortion pill safety study: WSJ
The FDA isĀ investigating the safety of mifepristone, an initiative that could allow the administration to impose restrictions on its use, WSJ reports.
Kevin Dunleavy
Jun 5, 2026 11:06am
Fierce Healthcare
Trump signs off on HHS overhaul of childhood vaccine schedule
Jun 1, 2026 2:00pm
CDER chief HĆøeg and CBER's Szarama exiting FDA posts
May 15, 2026 1:44pm
FDA's embattled Marty Makary steps down as commissioner
May 12, 2026 2:30pm
RFK Jr. continues to quietly probe vaccine safety: NYT
May 12, 2026 11:36am
HHS updates ACIP charter with new emphasis on vaccine safety
Apr 10, 2026 4:06pm